• Leonor García-Gómez, Andrea Hernández-Pérez, Valeri Noé-Díaz, Juan Antonio Riesco-Miranda, and Carlos Jiménez-Ruiz.
• Department of Research in Tobacco and COPD, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
• Rev Invest Clin. 2019 Jan 1; 71 (1): 7-16.

BackgroundSmoking is considered an epidemic, indeed, one of the most important public health problems worldwide. It is also the most significant preventable cause of death, of a high number of premature deaths, and avoidable chronic diseases. It is considered an enormous economic burden for the world.ObjectiveTo provide an overview of smoking-cessation treatments, including pharmacological and psychological options, and to gather current scientific evidence available on them.MethodsResearch included reviewing publications from 2007-2018 in four databases using algorithms related to bupropion, varenicline, nicotine replacement therapy, smoking cessation, psychological treatment, motivational interview, cognitive-behavioral therapy and clinical guidelines for smoking treatment. Meta-analyses or systematic reviews and randomized or quasi-randomized trials were selected. We also included clinical guidelines for smoking treatment from Mexico and other countries.ResultsAfter refining the search, 37 articles met the criteria and were included in the review. The results were grouped by type of intervention.ConclusionsIt is necessary to conduct research on combinations of both kinds of treatment with an integral, multidisciplinary vision. Current standard for smoking cessation is a combined psychological and pharmacological treatment.Copyright: © 2019 SecretarÍa de Salud.

21 keywords...

hide…